Jul 30,2019

DarioHealth Launches New Blood Pressure Monitoring System

DarioHealth Corp., a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. The Dario Blood Pressure Monitoring System assists patients with hypertension and is a critical part of DarioHealth's strategy to go beyond diabetes to reach patients with a variety of chronic conditions.

PRODUCT

#dtx

View Analyst & Ambassador Comments
Go to original news
Jul 31,2019

Insulet Appoints Jim Hollingshead to Board of Directors

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that Jim Hollingshead, Ph.D., has been appointed to the Company’s Board of Directors, effective immediately.

View Analyst & Ambassador Comments
Go to original news
Aug 09,2019

Dexcom Shares the Q2 2019 Results and Praises Growing CGM Awareness

Dexcom’s second quarter revenue hit $336 million, a 40% increase year over year. The company’s income was $7.8 million, or $0.08 per share. As a result of a stronger-than-expected first half, the company has adjusted its full-year 2019 revenue projection from $1.325 billion to $1.375 billion.

View Analyst & Ambassador Comments
Go to original news
Aug 14,2019

NHS scheme to support people at risk of developing Type 2 diabetes through digital means expanded

People at risk of developing Type 2 diabetes will receive digital support through a scheme that aims to prevent the condition from developing in England, part of the NHS Long Term Plan released at the beginning of the year.

View Analyst & Ambassador Comments
Go to original news
Aug 01,2019

Tandem Diabetes Care Announces Second Quarter 2019 Financial Results and Updated 2019 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2019 and updated its financial guidance for the year ending December 31, 2019. Domestic pump shipments increased 135 percent to 12,799 pumps in the second quarter of 2019 from 5,447 pumps in the same period of 2018. Domestic sales were $70.4 million, or an increase of 106 percent compared to $34.1 million in the second quarter of 2018.

View Analyst & Ambassador Comments
Go to original news
Aug 01,2019

Tandem Diabetes Care Announces No-Cost Software Updates for t:slim X2 Insulin Pump Customers in the United States

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 insulin pump customers in the United States through the end of 2020.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Aug 01,2019

Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced an $8 million (USD) senior credit facility from existing major shareholders, with the first $3.5 million available immediately, to help fund the Company’s European commercial launch plans. The non-dilutive credit facility will carry 8% interest with quarterly payments and the principal due only upon maturity in 5 years. The credit facility has no stock, warrants, or equity related instruments, or other associated expenses.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Aug 04,2019

Yes Health CDC-Recognized Programs for Diabetes Prevention and Weight Loss Joins Blue Shield of California Wellvolution Digital & Community-Health Network

Yes Health, a digital health company focused on preventing type 2 diabetes, has announced its CDC-recognized Diabetes Prevention Program (DPP) and all new Weight Loss Program (WLP), are now available to Blue Shield of California customers in the newly re-launched Wellvolution digital therapeutics and community-health based lifestyle medicine network.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Aug 05,2019

Insulet Reports Second Quarter 2019 Revenue of $177 Million, an Increase of 43% Year-Over-Year

Second quarter revenue of $177.1 million, up 43%, compared to revenue of $124.3 million in the prior year, exceeds guidance of $160 to $165 million.

View Analyst & Ambassador Comments
Go to original news
Aug 06,2019

DarioHealth to Present New Data at AADE Conference That Shows Improvement of Type 2 Diabetes Blood-glucose Levels Using MyDario™ App

DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to present the results of a new Dario app user study at the upcoming annual conference of the American Association of Diabetes Educators (AADE) in Houston, Texas on August 9-12, 2019.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES